Patents by Inventor Cheri Lubahn

Cheri Lubahn has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20090203646
    Abstract: The present invention concerns a method for reducing or preventing development of adhesions, fibrosis or scar tissue within serous body cavities by using sodium narcistatin.
    Type: Application
    Filed: February 12, 2009
    Publication date: August 13, 2009
    Inventors: Cheri Lubahn, Dianne Lorton
  • Patent number: 7550466
    Abstract: The present disclosure provides for improved methods for treating pain, including pain associated with chronic inflammatory diseases, neuropathic pain and cancer by using ?-adrenergic antagonists and ?-adrenergic agonists (particularly ?2-adrenergic agonists) alone or in combination.
    Type: Grant
    Filed: October 15, 2007
    Date of Patent: June 23, 2009
    Assignee: Sun Health Research Institute
    Inventors: Cheri Lubahn, Dianne Lorton
  • Patent number: 7462618
    Abstract: The present invention discloses a novel compound and method for the treatment of inflammatory autoimmune diseases, for example, rheumatoid arthritis, using ?-adrenergic antagonists and ?-adrenergic agonists in combination. Treatment of animals, namely humans, with an ?-adrenergic antagonist, preferably, phentolamine, and a ?-adrenergic agonist, preferably terbutaline, in combination can significantly suppress the joint destruction and inflammation due to disease in these animals.
    Type: Grant
    Filed: August 27, 2004
    Date of Patent: December 9, 2008
    Assignee: Sun Health Research Institute
    Inventors: Dianne Lorton, Cheri Lubahn
  • Publication number: 20080153830
    Abstract: The present disclosure provides for improved methods for treating pain, including pain associated with chronic inflammatory diseases, neuropathic pain and cancer by using ?-adrenergic antagonists and ?-adrenergic agonists (particularly ?2-adrenergic agonists) alone or in combination.
    Type: Application
    Filed: October 15, 2007
    Publication date: June 26, 2008
    Inventors: CHERI LUBAHN, Dianne Lorton
  • Publication number: 20050261246
    Abstract: The present invention provides methods for treating inflammatory conditions, rheumatoid diseases, autoimmune conditions, and conditions associated with bone loss, comprising administering to a subject with an inflammatory condition an amount effective to treat the condition of a compound selected from the group consisting of narcistatin, pancratistatin, pancratastatin-7? phosphate and pancratastatin-3?,4? cyclic phosphate, or pharmaceutically acceptable salts thereof.
    Type: Application
    Filed: March 4, 2005
    Publication date: November 24, 2005
    Inventors: Yung Chang, Dianne Lorton, Cheri Lubahn, George Pettit, David Wilson, Olga Ananieva
  • Publication number: 20050049256
    Abstract: The present invention discloses a novel compound and method for the treatment of inflammatory autoimmune diseases, for example, rheumatoid arthritis, using ?-adrenergic antagonists and ?-adrenergic agonists in combination. Treatment of animals, namely humans, with an ?-adrenergic antagonist, preferably, phentolamine, and a ?-adrenergic agonist, preferably terbutaline, in combination can significantly suppress the joint destruction and inflammation due to disease in these animals.
    Type: Application
    Filed: August 27, 2004
    Publication date: March 3, 2005
    Inventors: Dianne Lorton, Cheri Lubahn